Dr. Tanios S. Bekaii-Saab
Claim this profileMayo Clinic in Arizona
Studies Colorectal Cancer
Studies Cancer
14 reported clinical trials
29 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
BRAF negative
BRAF positive
2Cancer
Stage IV
Stage III
BRAF
Affiliated Hospitals
Clinical Trials Tanios S. Bekaii-Saab is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
ELI-002
for Colorectal Cancer
This trial is testing a new treatment called ELI-002 7P for patients with specific types of cancer. The treatment helps the immune system recognize and attack these cancer cells. ELI-002 7P targets mutations that are common in various cancers and have been studied for their role in tumor growth and resistance to treatments.
Recruiting1 award Phase 1 & 24 criteria
More about Tanios S. Bekaii-Saab
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Tanios S. Bekaii-Saab has experience with
- Regorafenib
- Lenvatinib
- Cabozantinib
- Atezolizumab
- Nab-paclitaxel
- Gemcitabine
Breakdown of trials Tanios S. Bekaii-Saab has run
Colorectal Cancer
Cancer
Adenocarcinoma
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tanios S. Bekaii-Saab specialize in?
Tanios S. Bekaii-Saab focuses on Colorectal Cancer and Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are BRAF negative.
Is Tanios S. Bekaii-Saab currently recruiting for clinical trials?
Yes, Tanios S. Bekaii-Saab is currently recruiting for 4 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Tanios S. Bekaii-Saab has studied deeply?
Yes, Tanios S. Bekaii-Saab has studied treatments such as Regorafenib, Lenvatinib, Cabozantinib.
What is the best way to schedule an appointment with Tanios S. Bekaii-Saab?
Apply for one of the trials that Tanios S. Bekaii-Saab is conducting.
What is the office address of Tanios S. Bekaii-Saab?
The office of Tanios S. Bekaii-Saab is located at: Mayo Clinic in Arizona, Scottsdale, Arizona 85259 United States. This is the address for their practice at the Mayo Clinic in Arizona.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.